Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
Clinical trial NCT02756637 · COMPLETED
Trial details
- NCT number
- NCT02756637
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-10-01
- Enrollment
- 634
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.